Details for New Drug Application (NDA): 011287
✉ Email this page to a colleague
The generic ingredient in KAYEXALATE is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Summary for 011287
Tradename: | KAYEXALATE |
Applicant: | Concordia |
Ingredient: | sodium polystyrene sulfonate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;ORAL, RECTAL | Strength | 453.6GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Complete Access Available with Subscription